Feliu, J., Borrega, P., León, A., López-Gómez, L., López, M., Castro, J., . . . González-Barón, M. (2011). Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. Cancer Chemotherapy & Pharmacology, 67(1), 215. https://doi.org/10.1007/s00280-010-1472-0
Chicago Style (17th ed.) CitationFeliu, J., et al. "Phase II Study of a Fixed Dose-rate Infusion of Gemcitabine Associated with Erlotinib in Advanced Pancreatic Cancer." Cancer Chemotherapy & Pharmacology 67, no. 1 (2011): 215. https://doi.org/10.1007/s00280-010-1472-0.
MLA (9th ed.) CitationFeliu, J., et al. "Phase II Study of a Fixed Dose-rate Infusion of Gemcitabine Associated with Erlotinib in Advanced Pancreatic Cancer." Cancer Chemotherapy & Pharmacology, vol. 67, no. 1, 2011, p. 215, https://doi.org/10.1007/s00280-010-1472-0.